(Q64128235)

English

Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Harriet L Robinson

7

object named as

Harriet Robinson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Michael Aidoo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ronald A Otten

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Vanessa Rodriguez

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Carlos A Sariol

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Melween Martinez

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Edmundo Kraiselburd

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Thomas Folks

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Salvatore Butera

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Dennis Ellenberger

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

0 references

publication date

29 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

6474-6481

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Cost-effectiveness of highly active antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Antiretroviral treatment in resource-poor settings: public health research priorities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

The challenges of host and viral diversity in HIV vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Loss of Viral Control in Early HIV‐1 Infection Is Temporally Associated with Sequential Escape from CD8+T Cell Responses and Decrease in HIV–1–Specific CD4+and CD8+T Cell Frequencies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Optimization of methods to assess human mucosal T-cell responses to HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6p stock virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.014

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.06.014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688978%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64128235&oldid=2001773633"